CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Evercore ISI Initiates First Tracks Biotherapeutics With Outperform Rating, $65 PT

Positive
AI Analysis

Summary

Evercore ISI initiated coverage of First Tracks Biotherapeutics with an Outperform rating and $65 price target.

Importance:3/10
Sentiment:
0.60
analyst_coverageprice_targetrating_initiation
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 11:23 AM

Read Original